您的位置: 首页 > 农业专利 > 详情页

B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
专利权人:
EMERGENT PRODUCT DEVELOPMENT SEATTLE; LLC
发明人:
PETER ARMSTRONG THOMPSON,WILLIAM BRADY,MARTHA SUSAN HAYDEN-LEDBETTER,SANDY ALEXANDER SIMON,LAURA SUE GROSMAIRE,JEFFREY A
申请号:
NZ59427506
公开号:
NZ594275A
申请日:
2006.07.25
申请国别(地区):
NZ
年份:
2013
代理人:
摘要:
594275 Disclosed is a humanized CD37-specific binding protein comprising: (a) human light chain framework regions, a light chain CDR1 comprising an amino acid sequence of SEQ ID NO:61, or 62, a light chain CDR2 comprising an amino acid sequence of SEQ ID NO:64, and a light chain CDR3 comprising an amino acid sequence of SEQ ID NO:66 and (b) human heavy chain framework regions, a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO:63, a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO:65, and a heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 67 or 68.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充